Dr John Russell and Neil Skolnik comment on how to translate the advisory committee on immunization practices influenza vaccination recommendations to patients.
Role Of Real-World Data To Explore Influenza Vaccination Health Outcomes
Dr Neil Skolnik reviews the role of real-world data to examine the efficacy of influenza vaccines and their impact on influenza related complications.
Communicating With Patients About MDD Treatment
October 5th 2023Roger S. McIntyre, MD, FRCPC; and Carmen Kosicek, MSN, PMHNP-BC, discuss provider and patient communication about the time to onset of action of major depressive disorder (MDD) treatments and when the patient can expect to see a difference.
Expert Opinions Of The Optimal Administration And Safety Of An Influenza Vaccine
A panel of experts in vaccination share their thoughts on the optimal timing and administration of an influenza vaccine for the general public.
Importance Of The Inclusion Of Multiple Viral Strains Within Vaccines
Dr Wendy Wright reviews the differences between influenza strains and the rationale for the inclusion of multiple viral strains within flu vaccines.
Insights Into The Currently Available Vaccine Technologies
Neil Skolnik, MD, reviews the currently available vaccine technologies, highlighting their mechanisms of action and individual delivery methods.
Expert Opinions On How To Increase Patient Education Surrounding Influenza Vaccination
A panel of experts in vaccination uptake strategies discuss their best practices for empowering their patients to obtain flu vaccines and discuss how to personalize these conversations.
Role Of Patient Education And Empowerment In Vaccination Efforts
Jacinda Abdul-Mutakabbir, PHARMD, MPH, AAHIVP, leads a conversation on the importance of vaccination in the defense and protection against viral infections, such as the flu.
A Conversation On The Perspective Change Surrounding The Impact Of Influenza
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, shares her thoughts on the changing perception of influenza and influenza vaccination post the COVID-19 pandemic.
Infant Weight and Efficacy Outcomes of Nirsevimab for RSV
September 18th 2023Experts discuss how infant weight related to efficacy outcomes of nirsevimab for Respiratory Syncytial Virus (RSV), providing their clinical expertise on why this may have occurred and what improvements can be made to mitigate these differences.